000739:SHE
Apeloa Pharmaceutical Co Ltd
CN¥ 23.42
arrow_downward
-1.64%(-0.39) Siku 1
16 Okt, 15:04:48 GMT +8 · CNY
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 000739...
Fungua
CN¥ 24.04
Juu
CN¥ 24.76
Chini
CN¥ 23.09
Mtaji wa soko
27.13B
Wastani wa kiasi cha mauzo
16.27M
Kiasi cha mauzo ya hisa
15.09M
Gawio
1.61%
Mgawo wa faida wa kila robo mwaka
CN¥ 0.09
Tarehe ya kutojumuisha gawio
8 Okt 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
31.78
Juu kwa wiki 52
CN¥ 28.50
Chini kwa wiki 52
CN¥ 14.89
EPS
CN¥ 0.74
Hisa za wawekezaji
1.16B
Idadi ya wafanyakazi
elfu 7
Fungua
CN¥ 24.04
Juu
CN¥ 24.76
Chini
CN¥ 23.09
Mtaji wa soko
27.13B
Wastani wa kiasi cha mauzo
16.27M
Kiasi cha mauzo ya hisa
15.09M
Gawio
1.61%
Mgawo wa faida wa kila robo mwaka
CN¥ 0.09
Tarehe ya kutojumuisha gawio
8 Okt 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
31.78
Juu kwa wiki 52
CN¥ 28.50
Chini kwa wiki 52
CN¥ 14.89
EPS
CN¥ 0.74
Hisa za wawekezaji
1.16B
Idadi ya wafanyakazi
elfu 7
Hisa zinazohusiana
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Foreign Policy Journal
·
dakika 27 zilizopita
Super Micro Computer (NASDAQ: SMCI) Signals Were Visible Before Its Stock 45% Rally
Yahoo Finance
·
saa 11 zilizopita
Michael Burry Warns of a Stock Market ‘Supervolcano’
AOL.com
·
saa 7 zilizopita
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
MarketWatch
·
saa 6 zilizopita
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Wasifu
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
Kuhusu Apeloa Pharmaceutical Co Ltd